Celularity Inc. closes financing deal with Philip A. Barach, co-founder of DoubleLine Capital LP.
On December 22, 2025, in Florham Park, New Jersey, Celularity Inc. (Nasdaq: CELU), a company specializing in regenerative and cellular medicine for age-related and degenerative diseases, revealed the completion of its recent financial deals with Philip A. Barach, the ex-president and co-founder of DoubleLine Capital LP.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments